Pharmaceuticals

FDA grants accelerated approval to Amgen’s Imdeltora to treat adults with advanced small cell lung cancer

bexib
By bexib 0 Min Read

Imdelltra (tarlatamab-dlle) is the first T-cell engager therapy approved for extensive-stage small cell lung cancer.

You Might Also Like

Understanding the impact of the Veradigm network on value-based healthcare delivery

Study finds headache medicine may prevent acute migraine medication overuse

Researchers develop genetic mole-removal therapy for rare skin disease

Merck Initiates Shorespan-007 Clinical Trial of Bomedemstat for Essential Thrombocythemia

AbbVie and Gilgamesh Pharmaceuticals agree to terms of collaboration to develop advanced treatments for mental illnesses

Share This Article
Previous Article The best email marketing tells a story
Next Article Exciting American-themed bar and restaurant opens in Liverpool’s iconic cultural quarter
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

SUMSUB starts Australian DVS verification of safe ID check
Fintech
Indian cash -free payments secure the $ 53 million US funded by PUBG Publisher Krafton.
Fintech
Late onboarding promotes clients’ losses at Singapore banks.
Fintech
The gorgeous spa Hotelgal Goma Resort will join the elegant hotel collection as the first member of the North Ireland
Hospitality & Tourism